- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Ex Vivo Metrics™, a preclinical tool in new drug development ; volume:6 ; number:1 ; day:23 ; month:1 ; year:2008 ; pages:1-5 ; date:12.2008
Journal of translational medicine ; 6, Heft 1 (23.1.2008), 1-5, 12.2008
- Creator
-
Curtis, C Gerald
- Contributor
-
Bilyard, Kevin
Stephenson, Hugo
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-6-5
- URN
-
urn:nbn:de:1111-2016041432700
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Curtis, C Gerald
- Bilyard, Kevin
- Stephenson, Hugo
- SpringerLink (Online service)
Other Objects (12)
Oromucosal drug delivery: Implementation of standardized and physiologically relevant ex vivo permeation studies in preclinical drug development
Modulated evaluation metrics for drug-based ontologies
Preclinical ex-vivo testing of anti-inflammatory drugs in a bovine intervertebral degenerative disc model
In vivo molecular imaging in preclinical research
Empirical software metrics for benchmarking of verification tools
Evaluating tropical phytoplankton phenology metrics using contemporary tools
Cherenkov luminescence imaging is a fast and relevant preclinical tool to assess tumour hypoxia in vivo
Human iPSC‐Derived Blood‐Brain Barrier Models: Valuable Tools for Preclinical Drug Discovery and Development?
Preclinical in-vivo-micro-CT of the heart
Onchocerciasis drug development: from preclinical models to humans
PET Imaging in Preclinical Anti-Aβ Drug Development
Cerenkov luminescence imaging is an effective preclinical tool for assessing colorectal cancer PD-L1 levels in vivo
Oromucosal drug delivery: Implementation of standardized and physiologically relevant ex vivo permeation studies in preclinical drug development
Modulated evaluation metrics for drug-based ontologies
Preclinical ex-vivo testing of anti-inflammatory drugs in a bovine intervertebral degenerative disc model
In vivo molecular imaging in preclinical research
Empirical software metrics for benchmarking of verification tools
Evaluating tropical phytoplankton phenology metrics using contemporary tools
Cherenkov luminescence imaging is a fast and relevant preclinical tool to assess tumour hypoxia in vivo
Human iPSC‐Derived Blood‐Brain Barrier Models: Valuable Tools for Preclinical Drug Discovery and Development?
Preclinical in-vivo-micro-CT of the heart
Onchocerciasis drug development: from preclinical models to humans
PET Imaging in Preclinical Anti-Aβ Drug Development
Cerenkov luminescence imaging is an effective preclinical tool for assessing colorectal cancer PD-L1 levels in vivo
Oromucosal drug delivery: Implementation of standardized and physiologically relevant ex vivo permeation studies in preclinical drug development
Modulated evaluation metrics for drug-based ontologies
Preclinical ex-vivo testing of anti-inflammatory drugs in a bovine intervertebral degenerative disc model
In vivo molecular imaging in preclinical research
Empirical software metrics for benchmarking of verification tools
Evaluating tropical phytoplankton phenology metrics using contemporary tools
Cherenkov luminescence imaging is a fast and relevant preclinical tool to assess tumour hypoxia in vivo
Human iPSC‐Derived Blood‐Brain Barrier Models: Valuable Tools for Preclinical Drug Discovery and Development?
Preclinical in-vivo-micro-CT of the heart
Onchocerciasis drug development: from preclinical models to humans
PET Imaging in Preclinical Anti-Aβ Drug Development